C37H30FNP.Br
Neat
538.63 79.90
-20°C
Room Temperature
154057-58-6; DTXSID70677142; ((2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methyl)(triphenyl)phosphanium bromide; {[2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]methyl}(triphenyl)phosphanium bromide; RefChem:1048835; DTXCID40627891; ((2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methyl)triphenylphosphonium bromide; MFCD19440813; Phosphonium, [[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]methyl]triphenyl- and bromide (1:1); [2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphonium bromido; C37H30BrFNP; [[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]methyl]triphenyl-phosphonium Bromide; [2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphonium bromide; [2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]methyl-triphenylphosphanium;bromide; {[2-CYCLOPROPYL-4-(4-FLUOROPHENYL)QUINOLIN-3-YL]METHYL}TRIPHENYLPHOSPHANIUM BROMIDE; [[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]methyl]triphenylphosphonium Bromide; Pitavastatin Impurity 28; SCHEMBL4537730; AKOS015904381; AC-24412
[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]methyl-triphenylphosphanium bromide
InChI=1S/C37H30FNP.BrH/c38-29-24-22-27(23-25-29)36-33-18-10-11-19-35(33)39-37(28-20-21-28)34(36)26-40(30-12-4-1-5-13-30,31-14-6-2-7-15-31)32-16-8-3-9-17-32;/h1-19,22-25,28H,20-21,26H2;1H/q+1;/p-1